These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8144213

  • 1. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
    Campbell DJ, Kladis A, Duncan AM.
    Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
    [Abstract] [Full Text] [Related]

  • 2. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 3. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 4. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM, Burrell LM, Kladis A, Campbell DJ.
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071
    [Abstract] [Full Text] [Related]

  • 5. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
    Campbell DJ, Duncan AM, Kladis A, Harrap SB.
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):426-36. PubMed ID: 8583785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
    Campbell DJ, Kladis A, Valentijn AJ.
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat.
    Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL.
    Hypertension; 1995 May; 25(5):1014-20. PubMed ID: 7737708
    [Abstract] [Full Text] [Related]

  • 10. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
    Campbell DJ, Zhang Y, Kelly DJ, Gilbert RE, McCarthy DJ, Shi W, Smyth GK.
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE.
    Circulation; 2005 May 24; 111(20):2605-10. PubMed ID: 15897343
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
    Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ.
    Hypertension; 1991 Dec 24; 18(6):763-73. PubMed ID: 1660448
    [Abstract] [Full Text] [Related]

  • 16. Bradykinin peptides in kidney, blood, and other tissues of the rat.
    Campbell DJ, Kladis A, Duncan AM.
    Hypertension; 1993 Feb 24; 21(2):155-65. PubMed ID: 8428778
    [Abstract] [Full Text] [Related]

  • 17. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM.
    Am J Physiol Heart Circ Physiol; 2006 Nov 24; 291(5):H2166-72. PubMed ID: 16766648
    [Abstract] [Full Text] [Related]

  • 18. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
    Grima M, Ingert C, Michel B, Barthelmebs M, Imbs JL.
    Clin Exp Hypertens; 1997 Nov 24; 19(5-6):671-85. PubMed ID: 9247747
    [Abstract] [Full Text] [Related]

  • 19. Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme.
    Chai SY, Perich R, Jackson B, Mendelsohn FA, Johnston CI.
    Clin Exp Pharmacol Physiol Suppl; 1992 Nov 24; 19():7-12. PubMed ID: 1327597
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
    Bohlender J, Bader M, Ménard J, Nussberger J.
    J Hypertens; 2012 Aug 24; 30(8):1597-605. PubMed ID: 22728903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.